| Authors: |
Boyd SD; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products., Sampson MR; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Clinical Pharmacology IV, Silver Spring, Maryland, USA., Viswanathan P; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products., Struble KA; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products., Arya V; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Clinical Pharmacology IV, Silver Spring, Maryland, USA., Sherwat AI; Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Division of Antiviral Products. |
